Eisai, Biogen (BIIB) Alzheimer drug granted FDA accelerated approval

Go back to Eisai, Biogen (BIIB) Alzheimer drug granted FDA accelerated approval
BIOGEN IDEC Inc. (NASDAQ: BIIB) Delayed: 216.73 +2.38 (1.11%)
Previous Close $214.35    52 Week High $333.65 
Open $217.76    52 Week Low $223.02 
Day High $219.12    P/E 27.75 
Day Low $215.00    EPS $7.81 
Volume 414,482